(Reuters) - Drug distributor Cardinal Health Inc said on Friday it would sell its Cordis medical device business to private equity firm Hellman & Friedman in a deal valued at about $1 billion.
Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila
Our Standards: The Thomson Reuters Trust Principles.
Disclaimer: The views expressed are solely those of the author and do not represent the official position of Followme. Followme does not take responsibility for the accuracy, completeness, or reliability of the information provided and is not liable for any actions taken based on the content, unless explicitly stated in writing.
Like this article? Show your appreciation by sending a tip to the author.
Leave Your Message Now